BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6633997)

  • 21. Clear cell adenocarcinoma of the cervix in a child without in utero exposure to diethylstilbestrol: a case report and review of the literature.
    Ahrens WA; Barrón-Rodriguez LP; McKee M; Rivkees S; Reyes-Múgica M
    Pediatr Dev Pathol; 2005; 8(6):690-5. PubMed ID: 16222478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma.
    Waggoner SE; Mittendorf R; Biney N; Anderson D; Herbst AL
    Gynecol Oncol; 1994 Nov; 55(2):238-44. PubMed ID: 7959291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of vaginal adenocarcinoma after uterine exposure to diethylstilbestrol].
    Schreiner WE; Bronz L; Wyss-Bernet M; Genton CY
    Schweiz Med Wochenschr; 1985 Nov; 115(44):1555-61. PubMed ID: 3841230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Teratogenic effect of diethylstilbestrol during pregnancy; the extent of the DES problem in the Netherlands].
    Stolk JG; Vooijs GP; Aartsen EJ; Heintz AP
    Ned Tijdschr Geneeskd; 1982 Jul; 126(30):1350-8. PubMed ID: 7133167
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of clear cell adenocarcinoma in DES-exposed offspring under observation.
    Kaufman RH; Korhonen MO; Strama T; Adam E; Kaplan A
    Obstet Gynecol; 1982 Jun; 59(6 Suppl):68S-72S. PubMed ID: 7088431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix.
    Waggoner SE; Anderson SM; Van Eyck S; Fuller J; Luce MC; Herbst AL
    Obstet Gynecol; 1994 Sep; 84(3):404-8. PubMed ID: 8058239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosquamous carcinoma of the cervix in a woman exposed to diethylstilbestrol in utero.
    Vandrie DM; Puri S; Upton RT; DeMeester LJ
    Obstet Gynecol; 1983 Mar; 61(3 Suppl):84S-87S. PubMed ID: 6823400
    [No Abstract]   [Full Text] [Related]  

  • 28. Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina.
    Hill EC
    Trans Pac Coast Obstet Gynecol Soc; 1972; 40():15-29. PubMed ID: 4668177
    [No Abstract]   [Full Text] [Related]  

  • 29. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol.
    Reich O; Tamussino K; Lahousen M; Pickel H; Haas J; Winter R
    Gynecol Oncol; 2000 Mar; 76(3):331-5. PubMed ID: 10684706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clear cell renal carcinoma in a pregnant DES-exposed patient.
    Mansi ML
    J Am Osteopath Assoc; 1989 Jul; 89(7):929-32. PubMed ID: 2768009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical and psychological effects of DES on exposed offspring.
    Konicki AM
    Cancer Nurs; 1985 Aug; 8(4):233-7. PubMed ID: 3850790
    [No Abstract]   [Full Text] [Related]  

  • 32. [Consequences of diethylstilbestrol during pregnancy; 50 years later still a significant problem].
    Treffers PE; Hanselaar AG; Helmerhorst TJ; Koster ME; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2001 Apr; 145(14):675-80. PubMed ID: 11530703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol.
    Herbst AL; Anderson D
    Semin Surg Oncol; 1990; 6(6):343-6. PubMed ID: 2263810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DES exposure and the aging woman: mothers and daughters.
    Laitman CJ
    Curr Womens Health Rep; 2002 Oct; 2(5):390-3. PubMed ID: 12215312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diethylstilbestrol-related clear-cell adenocarcinoma in women with initial examinations demonstrating no malignant disease.
    Kramer MS; Seltzer V; Krumholz B; Talebian F; Tedeschi C; Chen S
    Obstet Gynecol; 1987 Jun; 69(6):868-71. PubMed ID: 3574818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathology of vaginal and cervical abnormalities associated with prenatal exposure to diethylstilbestrol (des).
    Robboy SJ; Scully RE; Herbst AL
    J Reprod Med; 1975 Jul; 15(1):13-18. PubMed ID: 1151939
    [No Abstract]   [Full Text] [Related]  

  • 37. [Female fertility prognosis and diethylstilbestrol. Personal data and review of the literature].
    Laurent S; Lanoue M; Lecomte C; Bourgeois L; Lecomte P
    J Gynecol Obstet Biol Reprod (Paris); 1998 Apr; 27(3):277-84. PubMed ID: 9648005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical and vaginal cancer detection at a regional diethylstilbestrol (DES) screening clinic.
    Piver MS; Lele SB; Baker TR; Sandecki A
    Cancer Detect Prev; 1988; 11(3-6):197-202. PubMed ID: 3390844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression of cervicovaginal abnormalities in DES-exposed women. A comparison of changes in sexually inactive women and the effects of the onset of sexual activity.
    Frank AR; Krumholz BA; Deutsch S
    J Reprod Med; 1985 May; 30(5):400-3. PubMed ID: 4009562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of clear cell adenocarcinoma in young females.
    Wharton JT; Rutledge FN; Gallager HS; Fletcher G
    Obstet Gynecol; 1975 Apr; 45(4):365-8. PubMed ID: 1121369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.